The Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) recently announced its 2022 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.
Some highlights from the report include:
- There has been a 35% decrease in domestic sales and distribution of medically important antimicrobial drugs since 2015
- Medically-important sales and distribution by species:
- 41% estimated for use in cattle
- 43% estimated for use in swine
- 12% estimated for use in turkeys
- 2% estimated for use in chickens
- 2% estimated for use in other species/unknown
- For chicken, medically important estimated annual totals are:
- 2016 – 508,800 kgs
- 2017 – 268,047 kgs
- 2018 – 221,774 kgs
- 2019 – 192,964 kgs
- 2020 – 141,793 kgs
- 2021 – 158,342 kgs
- 2022 – 152,350 kgs
- There has been a 4% reduction between 2021 and 2022
- There has been a 70% reduction between 2016 and 2022
- There was almost a 4% decrease in non-medically important antibiotics marketed to all species between 2021 and 2022
- There was a 12% decrease in non-medically important antibiotics marketed to chickens between 2021 and 2022
